S100A6 expression has been associated with protection from TNF-α-induced apoptosis in cardiomyocytes [25], decreased metastasis rate in cancer of the bone [26], as well as the regulation of cell cycle progression [27]. The gene discussed is S100A6; the disease is cancer.